Advanced Glycation End Products Induce Peroxisome Proliferator-activated Receptor γ Down-regulation-related Inflammatory Signals in Human Chondrocytes Via Toll-like Receptor-4 and Receptor for Advanced Glycation End Products

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Jun 19

PMID 23776688

Citations 43

Authors

Ying Ju Chen

Meei Ling Sheu

Keh Sung Tsai

Rong Sen Yang

Shing Hwa Liu

Affiliations

Soon will be listed here.

Abstract

Accumulation of advanced glycation end products (AGEs) in joints is important in the development of cartilage destruction and damage in age-related osteoarthritis (OA). The aim of this study was to investigate the roles of peroxisome proliferator-activated receptor γ (PPARγ), toll-like receptor 4 (TLR4), and receptor for AGEs (RAGE) in AGEs-induced inflammatory signalings in human OA chondrocytes. Human articular chondrocytes were isolated and cultured. The productions of metalloproteinase-13 and interleukin-6 were quantified using the specific ELISA kits. The expressions of related signaling proteins were determined by Western blotting. Our results showed that AGEs enhanced the productions of interleukin-6 and metalloproteinase-13 and the expressions of cyclooxygenase-2 and high-mobility group protein B1 and resulted in the reduction of collagen II expression in human OA chondrocytes. AGEs could also activate nuclear factor (NF)-κB activation. Stimulation of human OA chondrocytes with AGEs significantly induced the up-regulation of TLR4 and RAGE expressions and the down-regulation of PPARγ expression in a time- and concentration-dependent manner. Neutralizing antibodies of TLR4 and RAGE effectively reversed the AGEs-induced inflammatory signalings and PPARγ down-regulation. PPARγ agonist pioglitazone could also reverse the AGEs-increased inflammatory signalings. Specific inhibitors for p38 mitogen-activated protein kinases, c-Jun N-terminal kinase and NF-κB suppressed AGEs-induced PPARγ down-regulation and reduction of collagen II expression. Taken together, these findings suggest that AGEs induce PPARγ down-regulation-mediated inflammatory signalings and reduction of collagen II expression in human OA chondrocytes via TLR4 and RAGE, which may play a crucial role in the development of osteoarthritis pathogenesis induced by AGEs accumulation.

Citing Articles

Identification and validation of up-regulated TNFAIP6 in osteoarthritis with type 2 diabetes mellitus.

Liu S, Chen H, Yang X, Wen Y, Chen L Sci Rep. 2024; 14(1):31450.

PMID: 39733138 PMC: 11682049. DOI: 10.1038/s41598-024-82985-5.

Retraction: Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products.

Chen Y, Sheu M, Tsai K, Yang R, Liu S PLoS One. 2024; 19(5):e0303122.

PMID: 38691543 PMC: 11062531. DOI: 10.1371/journal.pone.0303122.

Advanced glycation end products promote meniscal calcification by activating the mTOR-ATF4 positive feedback loop.

Yang S, Xie J, Pan Z, Guan H, Tu Y, Ye Y Exp Mol Med. 2024; 56(3):630-645.

PMID: 38424194 PMC: 10985079. DOI: 10.1038/s12276-024-01190-6.

Cabozantinib prevents AGEs-induced degradation of type 2 collagen and aggrecan in human chondrocytes.

Dong Y, Lin L, Ji Y, Cheng X, Zhang Z Aging (Albany NY). 2023; 15(23):13646-13654.

PMID: 38059882 PMC: 10756107. DOI: 10.18632/aging.205186.

Pioglitazone-Loaded Cartilage-Targeted Nanomicelles (Pio@C-HA-DOs) for Osteoarthritis Treatment.

Chen J, Xu W, Dai T, Jiao S, Xue X, Jiang J Int J Nanomedicine. 2023; 18:5871-5890.

PMID: 37873552 PMC: 10590558. DOI: 10.2147/IJN.S428938.

References

Verzijl N, DeGroot J, Ben Z, Maroudas A, Bank R, Mizrahi J . Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002; 46(1):114-23. DOI: 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P. View

Felson D, Zhang Y . An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998; 41(8):1343-55. DOI: 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9. View

Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier J, Duval N . Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Arthritis Res Ther. 2007; 9(2):R31. PMC: 1906809. DOI: 10.1186/ar2151. View

Fahmi H, Martel-Pelletier J, Pelletier J, Kapoor M . Peroxisome proliferator-activated receptor gamma in osteoarthritis. Mod Rheumatol. 2010; 21(1):1-9. DOI: 10.1007/s10165-010-0347-x. View

van Lent P, Blom A, Grevers L, Sloetjes A, van den Berg W . Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10. Ann Rheum Dis. 2006; 66(3):334-40. PMC: 1856016. DOI: 10.1136/ard.2006.057471. View

Akira S, Taga T, Kishimoto T . Interleukin-6 in biology and medicine. Adv Immunol. 1993; 54:1-78. DOI: 10.1016/s0065-2776(08)60532-5. View

Rasheed Z, Haqqi T . Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes. Biochim Biophys Acta. 2012; 1823(12):2179-89. PMC: 4509732. DOI: 10.1016/j.bbamcr.2012.08.021. View

Fahmi H, Di Battista J, Pelletier J, Mineau F, Ranger P, Martel-Pelletier J . Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 2001; 44(3):595-607. DOI: 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8. View

Glass G . Osteoarthritis. Dis Mon. 2006; 52(9):343-62. DOI: 10.1016/j.disamonth.2006.09.001. View

10.

Degroot J, Verzijl N, Jacobs K, Budde M, Bank R, Bijlsma J . Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage. 2002; 9(8):720-6. DOI: 10.1053/joca.2001.0469. View

11.

McCance D, Dyer D, Dunn J, Bailie K, Thorpe S, Baynes J . Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest. 1993; 91(6):2470-8. PMC: 443307. DOI: 10.1172/JCI116482. View

12.

Medzhitov R . Toll-like receptors and innate immunity. Nat Rev Immunol. 2002; 1(2):135-45. DOI: 10.1038/35100529. View

13.

van Beijnum J, Buurman W, Griffioen A . Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008; 11(1):91-9. DOI: 10.1007/s10456-008-9093-5. View

14.

Yang Q, Chen C, Wu S, Zhang Y, Mao X, Wang W . Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway. Eur J Pharmacol. 2010; 649(1-3):108-14. DOI: 10.1016/j.ejphar.2010.09.025. View

15.

Loeser R, Yammani R, Carlson C, Chen H, Cole A, Im H . Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum. 2005; 52(8):2376-85. PMC: 1488730. DOI: 10.1002/art.21199. View

16.

Billinghurst R, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C . Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997; 99(7):1534-45. PMC: 507973. DOI: 10.1172/JCI119316. View

17.

Goldring M, Goldring S . Osteoarthritis. J Cell Physiol. 2007; 213(3):626-34. DOI: 10.1002/jcp.21258. View

18.

Wolff D, Stevenson S, Goldberg V . S-100 protein immunostaining identifies cells expressing a chondrocytic phenotype during articular cartilage repair. J Orthop Res. 1992; 10(1):49-57. DOI: 10.1002/jor.1100100106. View

19.

Nah S, Choi I, Yoo B, Kim Y, Moon H, Lee C . Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett. 2007; 581(9):1928-32. DOI: 10.1016/j.febslet.2007.03.090. View

20.

Chawla A, Schwarz E, Dimaculangan D, Lazar M . Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 1994; 135(2):798-800. DOI: 10.1210/endo.135.2.8033830. View